Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Depreciation & Amortization (CF) readings, the most recent being $14796.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 56.75% to $14796.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $65223.0, a 156.14% increase, with the full-year FY2025 number at $59866.0, up 156.81% from a year prior.
  • Depreciation & Amortization (CF) hit $14796.0 in Q1 2026 for Pharma-Bio Serv, down from $15817.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $18866.0 in Q2 2025 to a low of $4589.0 in Q3 2024.
  • Median Depreciation & Amortization (CF) over the past 5 years was $12800.0 (2022), compared with a mean of $11598.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): tumbled 59.75% in 2024 and later surged 243.08% in 2025.
  • Pharma-Bio Serv's Depreciation & Amortization (CF) stood at $12800.0 in 2022, then plummeted by 42.25% to $7392.0 in 2023, then decreased by 19.81% to $5928.0 in 2024, then surged by 166.82% to $15817.0 in 2025, then fell by 6.46% to $14796.0 in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $14796.0 (Q1 2026), $15817.0 (Q4 2025), and $15744.0 (Q3 2025) per Business Quant data.